Search the Newsreel

Investors Title Company (NASDAQ: ITIC) lifts H1 2026 profit on premium growth

Investors Title Company (NASDAQ: ITIC) reported significantly stronger financial results for the first half of 2026, with total revenues increasing to $150.5 million and net income rising to $20.7 million. This growth was primarily driven by a 17.5% increase in net premiums written from …

INVESTORS TITLE CO Q2 2026: Revenue $86.5M, EPS $7.73— 10-Q Summary

Investors Title Co (ITIC) reported strong second-quarter 2026 results, with revenue increasing to $86.5 million and diluted earnings per share reaching $7.73. The growth was attributed to higher real estate activity, increased direct premiums, and significant investment gains. The company also expanded its operations …

Investors Title declares $0.46 per share dividend By Investing.com

Investors Title Company (NASDAQ:ITIC) announced a cash dividend of $0.46 per share, payable to shareholders of record as of September 1, 2026, with the payment date set for September 15, 2026. The company specializes in issuing and underwriting title insurance policies, providing services for …

Investors Title sets $0.46 cash dividend, payable Sept. 15

Investors Title Company (Nasdaq: ITIC) announced that its Board of Directors has declared a cash dividend of $0.46 per share. This dividend is payable on September 15, 2026, to shareholders of record as of September 1, 2026. The company is a North Carolina-based public …

Investors Title (NASDAQ:ITIC) Shares Gap Down - Time to Sell?

Investors Title (NASDAQ:ITIC) shares experienced a gap down before market open, trading at $284.46 after closing at $295.43. Despite a recent downgrade from "Buy" to "Hold" by Wall Street Zen, the stock maintains a consensus "Buy" rating. The company reported quarterly EPS of $7.73 …

European Lithium (ASX:EUR) Rises As Critical Metals Merger Nears Completion

European Lithium (ASX:EUR) shares rose by 5.76% as its merger with Nasdaq-listed Critical Metals Corp approaches completion. The merger, which aims to transform European Lithium shareholders' holdings from a small-cap lithium explorer into a stake in a larger rare earths and critical minerals developer, …

Apex Critical Metals Corp. (CN:APXC) Stock Slides as Investor Caution Returns to Critical Minerals Sector

Critical Metals Corp (CRML) Earnings Forecast: Future EPS & Revenue Growth Estimates

Investors Title (ITIC) Stock Pulls Back After Sharp Profit Jump

Investors Title (ITIC) stock experienced a 2% pullback despite reporting a strong Q2 2026 earnings jump, with basic EPS of US$7.75 and revenue of US$86.5m. This strong performance, showing increased revenue and wider net profit margins year-over-year, indicates the company's resilience in a choppy …

Critical Metals Corp (CRML) Stock Analysis & Forecast

This article provides an analysis and forecast for Critical Metals Corp (CRML) stock, highlighting its current market performance with a significant gain. It references a market recap discussing AI trends, geopolitical tensions, and specific company news like Qualcomm's AI surge and Microsoft's OpenAI unbundling, …

Analysts Are Updating Their Strata Critical Medical, Inc. (NASDAQ:SRTA) Estimates After Its Second-Quarter Results

Strata Critical Medical, Inc. (NASDAQ:SRTA) saw its shares rise 9.8% after its second-quarter results, despite a significant increase in statutory losses per share. Analysts have since updated their estimates, now predicting profitability for the company next year and a notable 12% improvement in 2026 …

CITIC Resources Sets August Board Meeting to Approve Interim Results and Consider Dividend

Investors Title Co (ITIC) Stock News Today

Critical Metals Corp (CRML) Stock News Today

Doubleview Gold Stock Surges 8.76% as Hat Project Exploration and Critical Metals Potential Attract Investor Interest

Brazilian Critical Minerals Expands Capital Base Through Performance Rights Conversion

Investors Title: Q2 Earnings Snapshot

Investors Title Co. (ITIC) reported a profit of $14.6 million in its second quarter, with net income reaching $7.73 per share. The Chapel Hill, North Carolina-based insurance company announced revenue of $86.5 million for the period. This financial snapshot was generated using data from …

Investors Title posts Q2 net income $14.6M; revenues up 17.5% to $86.5M

Investors Title (ITIC) reported a strong second quarter in 2026, with net income reaching $14.6 million, or $7.73 per diluted share, on revenues of $86.5 million, marking a 17.5% increase year-over-year. This growth was fueled by higher net premiums, increased escrow and title-related fees, …

Australian Critical Minerals Ltd (ASX: ACM) Share Price, ACM Stock News, ACM Share Price & Updates

Investors Title (NASDAQ:ITIC) Sees Large Volume Increase - Time to Buy?

Is Investors Title Co (ITIC) Overvalued After Strong Q2 Earnings

Press Release: Investors Title Company Announces Second Quarter 2026 Results

Investors Title Company (ITIC) announced its financial results for the second quarter of 2026. The company reported a decrease in net income to $8.2 million, or $4.33 per diluted share, compared to $9.5 million, or $5.00 per diluted share, in the prior year's second …

CITIC Securities Sets August Board Meeting to Review H1 2026 Results and Interim Dividend

Form 8K Investors Title Company For: 6 August By Investing.com

This article from Investing.com announces the filing of a Form 8K by Investors Title Company on August 6th. The content primarily consists of market data, financial instrument performance, and a list of trending stocks, but offers no further details regarding the specifics of the …

Investors Title reports $14.6M net income as revenue rises 17.5%

Investors Title Company announced strong second-quarter 2026 results, with net income rising to $14.6 million, or $7.73 per diluted share, up from $12.3 million in the prior year. Total revenues increased by 17.5% to $86.5 million, driven by higher net premiums written, escrow fees, …

Investors Title Company (Nasdaq: ITIC) Q2 net income hits $14.6M

Investors Title Company reported a strong second quarter for 2026, with net income rising to $14.6 million, or $7.73 per diluted share, up from $12.3 million in the previous year. Revenues increased 17.5% to $86.5 million, driven by higher net premiums written, escrow and …

Brazilian Critical Minerals (ASX:BCM) Rallies After Ema Study Defines the Development Case

CITIC Securities Raises RMB16 Billion in Targeted H-Share Issuance to Bolster Global Expansion

Can Strata Critical Medical, Inc. (SRTA) Run Higher on Rising Earnings Estimates?

Wall Street Zen Downgrades Investors Title (NASDAQ:ITIC) to Hold

Wall Street Zen downgraded Investors Title (NASDAQ:ITIC) from a "Buy" to a "Hold" rating. Despite this, Weiss Ratings upgraded ITIC to "Buy (B)," and MarketBeat's average rating for the stock remains "Buy." The company reported quarterly earnings of $3.20 per share on revenues of …

CITIC Securities: Is this round of Hong Kong stock market movement a rebound or a reversal?

Strata Critical Medical Reports Q2 2026 Results: Full Earnings Call Transcript

Strata Critical Medical reported strong Q2 2026 results with significant sequential growth in clinical revenue and increased clinical gross margins, driven by strategic acquisitions. The company raised its 2026 revenue and adjusted EBITDA guidance, reflecting accelerated clinical growth and M&A, despite short-term logistics margin …

AMG Critical Materials (ENXTAM:AMG) Stock Looks Near Fair Value After 35% Gain

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. AMG Critical Materials stock has returned 35.0% over the past year, and after that …

Investors Title (NASDAQ:ITIC) Stock Passes Above 200-Day Moving Average - Here's What Happened

Investors Title (NASDAQ:ITIC) stock has recently moved above its 200-day moving average, trading at $289.80, significantly higher than its average of $248.59. The company received a "Buy" rating from Weiss Ratings and an average "Buy" rating from MarketBeat, despite a "Hold" downgrade from Wall …

Strata Critical Medical (SRTA) Stock Faces Clinical Progress And Lingering Losses

Strata Critical Medical (SRTA) reported Q2 2026 results showing significant clinical revenue growth, reaching US$72.5m, and improved adjusted EBITDA margins, signaling a successful pivot towards clinical services. Despite these operational improvements and positive free cash flow, the company continues to face losses, a short …

Strata Critical Medical, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SRTA)

This article provides the slide deck published by Strata Critical Medical, Inc. (SRTA) in conjunction with their Q2 2026 earnings call. The content is presented by SA Transcripts, a team dedicated to publishing earnings call transcripts and related developments.